bioRxivMicrobiologyPreprint
Potent SARS-CoV-2 neutralizing antibodies selected from a human antibody library constructed decades ago
M. Qiang, P. Ma, Y. Li, H. Liu, A. Harding, C. Min, L. Liu, M. Yuan, Q. Ji, P. Tao, X. Shi, Z. Li, F. Wang, Y. Zhang, N. C. Wu, C.-C. D. Lee, X. Zhu, J. Gilbert-Jaramillo, A. Saxena, X. Huang, H. Wang, W. James, R. A. Dwek, I. A. Wilson, G. Yang, R. A. Lerner
Abstract
Combinatorial antibody libraries not only effectively reduce antibody discovery to a numbers game, but enable documentation of the history of antibody responses in an individual. The SARS-CoV-2 pandemic has prompted a wider application of this technology to meet the public health challenge of pandemic threats in the modern era. Herein, we used a combinatorial human antibody library constructed 20 years before the COVID-19 pandemic to discover three highly potent antibodies that selectively bind SARS-CoV-2 spike protein and neutralize authentic SARS-CoV-2 virus. Compared to neutralizing antibodies from COVID-19 patients with generally low somatic hypermutation (SHM), these antibodies contain over 13-22 SHMs, many of which are involved in specific interactions in crystal structures with SARS-CoV-2 spike RBD. The identification of these somatically mutated antibodies in a pre-pandemic library raises intriguing questions about the origin and evolution of human immune responses to SARS-CoV-2.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Neutralizing antibodies targeting the SARS-CoV-2 receptor binding domain isolated from a naïve human antibody library
B. N. Bell, A. E. Powell, … P. S. Kim·bioRxiv·Jan 7, 2021
- Cross-neutralization antibodies against SARS-CoV-2 and RBD mutations from convalescent patient antibody libraries
- Rapid selection of a human monoclonal antibody that potently neutralizes SARS-CoV-2 in two animal models
W. Li, A. Drelich, … D. S. Dimitrov·bioRxiv·May 13, 2020
- Discovery and Development of Human SARS-CoV-2 Neutralizing Antibodies using an Unbiased Phage Display Library Approach
X. Cao, J. Maruyama, … R. D. Allen·bioRxiv·Sep 27, 2020
- Bivalent binding of a fully human IgG to the SARS-CoV-2 spike proteins reveals mechanisms of potent neutralization
B. Wang, D. Asarnow, … C.-I. Wang·bioRxiv·Jul 14, 2020
- Molecular basis for a germline-biased neutralizing antibody response to SARS-CoV-2
S. A. Clark, L. E. Clark, … J. Abraham·bioRxiv·Nov 13, 2020